.
EDITOR-IN-CHIEF
Prof. I. Yakoub-Agha, Dept. of Haematology, Head of the Immune Cellular Therapy Unit, Lille University Hospital, Lille, France
EDITORS
Dr T. Alsuliman, Dept. of Haematology and cellular therapy, Saint-Antoine hospital, APHP, Paris ; Sorbonne University, Paris, France
Prof. M. Beksac, Dept. of Hematology, Ankara University, Ankara, Turkey
Prof. H. Bönig, Dept of Translational Development of Cellular Therapeutics, Institute for Transfusion Medicine and Immune Hematology, Johann-Wolfgang-Goethe Medical University, Frankfurt, Germany
Dr E. Brissot, Dept. of Haematology and cellular therapy, Saint-Antoine hospital, APHP, Paris ; Sorbonne University, Paris, France
Prof. G. Damaj, Dept. of Haematology, Caen University Hospital, Caen, France
Dr J. Demaret, Lille University Hospital, Lille, France
Dr R. Greco, Blood and Marrow Transplant Unit (BMT), San Raffaele Scientific Hospital (IRCCS), Milano, Italy
Prof. M. Guzman, Weill Cornell Medicine, New York, USA
Dr P. Hayden, St. James's hospital, Dublin, Ireland
Dr D. Humaidan, Eberhard Karls University of Tuebingen and Max Planck International Research School for Intelligent Systems (IMPRS-IS), Tuebingen, Germany
Prof. M. Ahmad Kassab, Research Associate, University of Pennsylvanian, Philadelphia, Pennsylvania, USA
Prof. M. Labalette, Lab of Immunology and HLA, Lille University Hospital, Lille, France
Prof. J. Larghero, Saint Louis Hospital, Paris, France
Prof. J. J. Melenhorst, University of Pennsylvania, Philadelphia, United States
Dr C. Roddie, University of London, London, UK
Prof. J. A Snowden, Consultant Haematologist & Director of Blood and Marrow Transplantation, Sheffi eld Teaching Hospitals NHS Foundation Trust Sheffi eld, UK
Prof. M. Subklewe, LMU University Hospital Munich, Munich, Germany
Dr A. Sureda, Blood Cell Barcelona Hematology Institute, Barcelona, Spain
.
BIOSTATISTICIAN
Dr M. Ordak, Centre for Preclinical, Research and Technology (CePT), Medical University of Warsaw, Poland
.
INTERNATIONAL SCIENTIFIC COMMITTEE
R. Burt (Northwestern University Feinberg School of Medicine, Chicago, United States), F. Calvo (INSERM U749, Villejuif, France), O. Cohen Haguenauer (University Institute of Geriatry of Sherbrooke, Paris, France), T. Fülop (Sherbrooke University of Applied Sciences Institute, Quebec, Canada), M.-P. Jacob-Lenet (INSERM, Cardiovascular Structural Diseases, Paris, France), M. Leboyer (University Hospital Centre Henri Mondor, Créteil, France), F.-X. Maquart (University Hospital Centre Reims Biochemistry Laboratory, Reims, France), J.-M. Molina (Saint Louis Hospital, Paris, France), J.-C. Monboisse (University Hospital Centre Reims Biochemistry Laboratory, Reims, France), N. Mazure (Nice, France)
Current Research in Translational Medicine. Cellular and Immune Therapy is a peer-reviewed journal, publishing worlwide clinical and basic research in the field of hematology, immunology, hematopoietic cell transplantation, and cellular and gene therapy. The journal considers for publication English-language editorials, original articles, reviews, and short reports including case-reports. Contributions are intended to draw attention to experimental medicine and translational research. Current Research in Translational Medicine periodically publishes thematic issues and is indexed in all major international databases. 2023 Impact Factor: 3.2. Source: 2023 Journal Citation Reports (Clarivate Analytics, 2024). 4 issues/year. E-journal
Core areas covered in Current Research in Translational Medicine are:
Current Research in Translational Medicine. Cellular and Immune Therapy is a peer-reviewed journal, publishing worlwide clinical and basic research in the field of hematology, immunology, hematopoietic cell transplantation, and cellular and gene therapy. The journal considers for publication English-language editorials, original articles, reviews, and short reports including case-reports. Contributions are intended to draw attention to experimental medicine and translational research. Current Research in Translational Medicine periodically publishes thematic issues and is indexed in all major international databases. 2023 Impact Factor: 3.2. Source: 2023 Journal Citation Reports (Clarivate Analytics, 2024). 4 issues/year. E-journal
Core areas covered in Current Research in Translational Medicine are:
2023 Impact Factor*: 3.2
*2023 Journal Citation Reports (Clarivate Analytics, 2024)
EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.
En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.
Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.
